Search research articles
Contact Us
Filters
Showing results (131-140 of 188) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2009
Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome
Wanlong Ma, Hagop Kantarjian, Benjamin Bekele, et al.
Cancer
|
July 25, 2003
Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia
Hagop M Kantarjian, Susan O'Brien, Jorge Cortes, et al.
American Journal of Hematology
|
July 29, 2016
Clinical and molecular characteristics of XPO1 mutations in patients with chronic lymphocytic leukemia
Preetesh Jain, Rashmi Kanagal-Shamanna, William Wierda, et al.
Clinical Lymphoma
|
April 10, 2004
Management guidelines for use of alemtuzumab in B-cell chronic lymphocytic leukemia
Michael Keating, Stephen Coutré, Kanti Rai, et al.
United European Gastroenterology Journal
|
February 1, 2025
Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis-A Safety Analysis
Anita Afzali, Miguel Regueiro, Andres J Yarur, et al.
Blood
|
October 15, 2005
Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia
Jacques-Louis Binet, Federico Caligaris-Cappio, Daniel Catovsky, et al.
Leukemia & Lymphoma
|
October 14, 2014
Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes
Ohad Benjamini, Preetesh Jain, Long Trinh, et al.
British Journal of Haematology
|
May 11, 2021
Clinical and molecular characteristics and treatment patterns of adolescent and young adult patients with chronic lymphocytic leukaemia
Hua-Jay J Cherng, Nadya Jammal, Shilpa Paul, et al.
Cancer
|
October 14, 2004
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia
Hagop Kantarjian, Deborah Thomas, Susan O'Brien, et al.
Cancer
|
August 27, 2004
Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies
Maher Albitar, Kim-Anh Do, Marcella M Johnson, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 188) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2009
Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome
Wanlong Ma, Hagop Kantarjian, Benjamin Bekele, et al.
Cancer
|
July 25, 2003
Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia
Hagop M Kantarjian, Susan O'Brien, Jorge Cortes, et al.
American Journal of Hematology
|
July 29, 2016
Clinical and molecular characteristics of XPO1 mutations in patients with chronic lymphocytic leukemia
Preetesh Jain, Rashmi Kanagal-Shamanna, William Wierda, et al.
Clinical Lymphoma
|
April 10, 2004
Management guidelines for use of alemtuzumab in B-cell chronic lymphocytic leukemia
Michael Keating, Stephen Coutré, Kanti Rai, et al.
United European Gastroenterology Journal
|
February 1, 2025
Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis-A Safety Analysis
Anita Afzali, Miguel Regueiro, Andres J Yarur, et al.
Blood
|
October 15, 2005
Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia
Jacques-Louis Binet, Federico Caligaris-Cappio, Daniel Catovsky, et al.
Leukemia & Lymphoma
|
October 14, 2014
Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes
Ohad Benjamini, Preetesh Jain, Long Trinh, et al.
British Journal of Haematology
|
May 11, 2021
Clinical and molecular characteristics and treatment patterns of adolescent and young adult patients with chronic lymphocytic leukaemia
Hua-Jay J Cherng, Nadya Jammal, Shilpa Paul, et al.
Cancer
|
October 14, 2004
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia
Hagop Kantarjian, Deborah Thomas, Susan O'Brien, et al.
Cancer
|
August 27, 2004
Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies
Maher Albitar, Kim-Anh Do, Marcella M Johnson, et al.
Page
of 19